Scrip Dividend Declaration

RNS Number : 4315Z

The MedicX Fund Limited

10 December 2014

 



For immediate release

10 December 2014

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Scrip Dividend Declaration

MedicX Fund (LSE: MXF) announces that, pursuant to its scrip dividend scheme (the "Scrip Dividend Alternative"), elections were received in respect of 11.6 per cent. of the ordinary shares in issue as at the record date of 14 November 2014.  Electing shareholders will receive ordinary shares of no par value in the Company ("Shares") in lieu of receiving cash for the December 2014 dividend in respect of the quarter ended 30 September 2014.  Accordingly, 718,517 Shares will be sold out of treasury by the Company on 31 December 2014 to shareholders who elected to participate in the Scrip Dividend Alternative.

The Shares will rank pari passu with the existing ordinary shares.

Following the transaction, the Company will have 361,445,780 ordinary shares in issue, of which 3,338,175 will be held in treasury.  Accordingly the total voting rights in issue will be 358,107,605.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

End

For further information please contact:

MedicX Fund                                                                  [phone]

David Staples, Chairman

Octopus Healthcare Group                                               [phone]

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Canaccord                                                                       [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan                                                                        [phone]

Charles Ryland/Sophie McNulty

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 137 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the Octopus Healthcare Group. The Octopus Healthcare Group is a specialist investor, developer and manager of healthcare properties with 33 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement. 

 

END

 

 

DIVQBLFFZLFLFBQ